Charite University, Berlin, Germany

Charité – Universitätsmedizin Berlin is Europe’s largest university hospital and a co-lead site of the BMBF-funded EPIsoDE Phase IIb psilocybin trial for treatment-resistant depression; its Psychedelic Substances Research Group under Prof. Tomislav Majć also investigates MDMA for PTSD and ketamine for depression.